May 18, 2023

Voyager Therapeutics

Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACERâ„¢-Generated Novel Capsids at the ASGCT 26th Annual Meeting

May 15, 2023

Fulcrum Therapeutics

Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer

May 15, 2023

Fulcrum Therapeutics

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

May 15, 2023

Decibel Therapeutics

Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

May 12, 2023

Decibel Therapeutics

Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO

Load More

Sign up for weekly portfolio news.